Structural insight into effector proteins of Gram-negative bacterial pathogens that modulate the phosphoproteome of their host

Protein Science

Volumn 24, Issue 5, 2015, Pages 604-620

  Grishin, Andrey M ^a   Beyrakhova, Ksenia A ^a   Cygler, Miroslaw ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

bacterial acetylases; bacterial effector kinases; bacterial phosphatases; bacterial phospholyases; noneukaryotic like kinases; structure function relationship

Indexed keywords

ACYLTRANSFERASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; PHOSPHATASE; PHOSPHOSERINE; PHOSPHOTHREONINE; PHOSPHOTRANSFERASE; PROTEIN TYROSINE PHOSPHATASE; BACTERIAL PROTEIN; PROTEOME;

AMINO ACID SEQUENCE; BACTERIAL VIRULENCE; EUKARYOTIC CELL; GRAM NEGATIVE BACTERIUM; HOST CELL; LEGIONELLA PNEUMOPHILA; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; TYPE III SECRETION SYSTEM; YERSINIA PESTIS; CHEMISTRY; ENZYMOLOGY; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; PATHOGENICITY; PHOSPHORYLATION;

BACTERIAL PROTEINS; GRAM-NEGATIVE BACTERIA; HOST-PATHOGEN INTERACTIONS; HUMANS; PHOSPHORIC MONOESTER HYDROLASES; PHOSPHORYLATION; PHOSPHOTRANSFERASES; PROTEOME;

EID: 84937987381     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1002/pro.2636     Document Type: Review

References (154)

1. Christie PJ, Whitaker N, Gonzalez-Rivera C, (2014) Mechanism and structure of the bacterial type IV secretion systems. Biochim Biophys Acta 1843: 1578-1591.
2. Diepold A, Wagner S, (2014) Assembly of the bacterial type III secretion machinery. FEMS Microbiol Rev 38: 802-822.
3. Kuhle V, Hensel M, (2004) Cellular microbiology of intracellular Salmonella enterica: functions of the type III secretion system encoded by Salmonella pathogenicity island 2. Cell Mol Life Sci 61: 2812-2826.
4. Galan JE, (2009) Common themes in the design and function of bacterial effectors. Cell Host Microbe 5: 571-579.
5. Dean P, (2011) Functional domains and motifs of bacterial type III effector proteins and their roles in infection. FEMS Microbiol Rev 35: 1100-1125.
6. Wong ARC, Pearson JS, Bright MD, Munera D, Robinson KS, Lee SF, Frankel G, Hartland EL, (2011) Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements. Mol Microbiol 80: 1420-1438.
7. Tobe T, Beatson SA, Taniguchi H, Abe H, Bailey CM, Fivian A, Younis R, Matthews S, Marches O, Frankel G, Hayashi T, Pallen MJ, (2006) An extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their dissemination. Proc Natl Acad Sci USA 103: 14941-14946.
8. Ninio S, Roy CR, (2007) Effector proteins translocated by Legionella pneumophila: strength in numbers. Trends Microbiol 15: 372-380.
9. Franco IS, Shuman HA, Charpentier X, (2009) The perplexing functions and surprising origins of Legionella pneumophila type IV secretion effectors. Cell Microbiol 11: 1435-1443.
10. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S, (2002) The protein kinase complement of the human genome. Science 298: 1912-1934.
11. Mustelin T, (2007) A brief introduction to the protein phosphatase families. Methods Mol Biol 365: 9-22.
12. Schmutz C, Ahrné E, Kasper CA, Tschon T, Sorg I, Dreier RF, Schmidt A, Arrieumerlou C, (2013) Systems-level overview of host protein phosphorylation during Shigella flexneri infection revealed by phosphoproteomics. Mol Cell Proteom 12: 2952-2968.
13. Rogers LD, Brown NF, Fang Y, Pelech S, Foster LJ, (2011) Phosphoproteomic analysis of Salmonella-infected cells identifies key kinase regulators and SopB-dependent host phosphorylation events. Science Signal 4: rs9.
14. Imami K, Bhavsar AP, Yu H, Brown NF, Rogers LD, Finlay BB, Foster LJ, (2013) Global impact of Salmonella pathogenicity island 2-secreted effectors on the host phosphoproteome. Mol Cell Proteom 12: 1632-1643.
15. Mukherjee S, Hao YH, Orth K, (2007) A newly discovered post-translational modification-the acetylation of serine and threonine residues. Trends Biochem Sci 32: 210-216.
16. Cui J, Shao F, (2011) Biochemistry and cell signaling taught by bacterial effectors. Trends Biochem Sci 36: 532-540.
17. Canova MJ, Molle V, (2014) Bacterial serine/threonine protein kinases in host-pathogen interactions. J Biol Chem 289: 9473-9479.
18. Cazalet C, Rusniok C, Bruggemann H, Zidane N, Magnier A, Ma L, Tichit M, Jarraud S, Bouchier C, Vandenesch F, Kunst F, Etienne J, Glaser P, Buchrieser C, (2004) Evidence in the Legionella pneumophila genome for exploitation of host cell functions and high genome plasticity. Nat Genet 36: 1165-1173.
19. Wehenkel A, Bellinzoni M, Grana M, Duran R, Villarino A, Fernandez P, Andre-Leroux G, England P, Takiff H, Cervenansky C, Cole ST, Alzari PM, (2008) Mycobacterial Ser/Thr protein kinases and phosphatases: physiological roles and therapeutic potential. Biochim Biophys Acta 1784: 193-202.
20. Poh J, Odendall C, Spanos A, Boyle C, Liu M, Freemont P, Holden DW, (2008) SteC is a Salmonella kinase required for SPI-2-dependent F-actin remodelling. Cell Microbiol 10: 20-30.
21. Wiley DJ, Shrestha N, Yang J, Atis N, Dayton K, Schesser K, (2009) The activities of the Yersinia protein kinase A (YpkA) and outer protein J (YopJ) virulence factors converge on an eIF2alpha kinase. J Biol Chem 284: 24744-24753.
22. Lurie-Weinberger MN, Gomez-Valero L, Merault N, Glockner G, Buchrieser C, Gophna U, (2010) The origins of eukaryotic-like proteins in Legionella pneumophila. Int J Med Microbiol 300: 470-481.
23. Hemrajani C, Berger CN, Robinson KS, Marches O, Mousnier A, Frankel G, (2010) NleH effectors interact with Bax inhibitor-1 to block apoptosis during enteropathogenic Escherichia coli infection. Proc Natl Acad Sci USA 107: 3129-3134.
24. Kim DW, Lenzen G, Page AL, Legrain P, Sansonetti PJ, Parsot C, (2005) The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes. Proc Natl Acad Sci USA 102: 14046-14051.
25. Fookes M, Schroeder GN, Langridge GC, Blondel CJ, Mammina C, Connor TR, Seth-Smith H, Vernikos GS, Robinson KS, Sanders M, Petty NK, Kingsley RA, Baumler AJ, Nuccio SP, Contreras I, Santiviago CA, Maskell D, Barrow P, Humphrey T, Nastasi A, Roberts M, Frankel G, Parkhill J, Dougan G, Thomson NR, (2011) Salmonella bongori provides insights into the evolution of the Salmonellae. PLoS Pathog 7: e1002191.
26. Matsumoto H, Young GM, (2006) Proteomic and functional analysis of the suite of Ysp proteins exported by the Ysa type III secretion system of Yersinia enterocolitica Biovar 1B. Mol Microbiol 59: 689-706.
27. Hanks SK, Hunter T, (1995) Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J 9: 576-596.
28. Grishin AM, Cherney M, Anderson DH, Phanse S, Babu M, Cygler M, (2014) NleH defines a new family of bacterial effector kinases. Structure 22: 250-259.
29. Grishin AM, Condos TE, Barber KR, Campbell-Valois FX, Parsot C, Shaw GS, Cygler M, (2014) Structural basis for the inhibition of host protein ubiquitination by Shigella effector kinase OspG. Structure 22: 878-888.
30. Halavaty AS, Anderson SM, Wawrzak Z, Kudritska M, Skarina T, Anderson WF, Savchenko A, (2014) Type III effector NleH2 from Escherichia coli O157:H7 str. Sakai features an atypical protein kinase domain. Biochemistry 53: 2433-2435.
31. Pruneda JN, Smith FD, Daurie A, Swaney DL, Villen J, Scott JD, Stadnyk AW, Le Trong I, Stenkamp RE, Klevit RE, Rohde JR, Brzovic PS, (2014) E2∼Ub conjugates regulate the kinase activity of Shigella effector OspG during pathogenesis. EMBO J 33: 437-449.
32. Hervet E, Charpentier X, Vianney A, Lazzaroni JC, Gilbert C, Atlan D, Doublet P, (2011) Protein kinase LegK2 is a type IV secretion system effector involved in endoplasmic reticulum recruitment and intracellular replication of Legionella pneumophila. Infect Immun 79: 1936-1950.
33. Garcia-Angulo VA, Deng W, Thomas NA, Finlay BB, Puente JL, (2008) Regulation of expression and secretion of NleH, a new non-locus of enterocyte effacement-encoded effector in Citrobacter rodentium. J Bacteriol 190: 2388-2399.
34. Thomas NA, Deng W, Puente JL, Frey EA, Yip CK, Strynadka NC, Finlay BB, (2005) CesT is a multi-effector chaperone and recruitment factor required for the efficient type III secretion of both LEE- and non-LEE-encoded effectors of enteropathogenic Escherichia coli. Mol Microbiol 57: 1762-1779.
35. Gao X, Wan F, Mateo K, Callegari E, Wang D, Deng W, Puente J, Li F, Chaussee MS, Finlay BB, Lenardo MJ, Hardwidge PR, (2009) Bacterial effector binding to ribosomal protein s3 subverts NF-kappaB function. PLoS Pathog 5: e1000708.
36. Wan F, Weaver A, Gao X, Bern M, Hardwidge PR, Lenardo MJ, (2011) IKKbeta phosphorylation regulates RPS3 nuclear translocation and NF-kappaB function during infection with Escherichia coli strain O157:H7. Nature Immunol 12: 335-343.
37. Pham TH, Gao X, Tsai K, Olsen R, Wan F, Hardwidge PR, (2012) Functional differences and interactions between the Escherichia coli type III secretion system effectors NleH1 and NleH2. Infect Immun 80: 2133-2140.
38. Martinez E, Schroeder GN, Berger CN, Lee SF, Robinson KS, Badea L, Simpson N, Hall RA, Hartland EL, Crepin VF, Frankel G, (2010) Binding to Na(+) /H(+) exchanger regulatory factor 2 (NHERF2) affects trafficking and function of the enteropathogenic Escherichia coli type III secretion system effectors Map, EspI and NleH. Cell Microbiol 12: 1718-1731.
39. Zhou Y, Dong N, Hu L, Shao F, (2013) The Shigella type three secretion system effector OspG directly and specifically binds to host ubiquitin for activation. PLoS One 8: e57558.
40. Kornev AP, Haste NM, Taylor SS, Eyck LF, (2006) Surface comparison of active and inactive protein kinases identifies a conserved activation mechanism. Proc Natl Acad Sci USA 103: 17783-17788.
41. Kornev AP, Taylor SS, Ten Eyck LF, (2008) A helix scaffold for the assembly of active protein kinases. Proc Natl Acad Sci USA 105: 14377-14382.
42. Pham TH, Gao X, Singh G, Hardwidge PR, (2013) Escherichia coli virulence protein NleH1 interaction with the v-Crk Sarcoma virus CT10 oncogene-like protein (CRKL) governs NleH1 inhibition of the ribosomal protein S3 (RPS3)/nuclear factor κB (NF-κB) pathway. J Biol Chem 288: 34567-34574.
43. Kamadurai HB, Souphron J, Scott DC, Duda DM, Miller DJ, Stringer D, Piper RC, Schulman BA, (2009) Insights into ubiquitin transfer cascades from a structure of a UbcH5B
44. Beal RE, Toscano-Cantaffa D, Young P, Rechsteiner M, Pickart CM, (1998) The hydrophobic effect contributes to polyubiquitin chain recognition. Biochemistry 37: 2925-2934.
45. Huang L, Kinnucan E, Wang G, Beaudenon S, Howley PM, Huibregtse JM, Pavletich NP, (1999) Structure of an E6AP-UbcH7 complex: insights into ubiquitination by the E2-E3 enzyme cascade. Science 286: 1321-1326.
46. Sloper-Mould KE, Jemc JC, Pickart CM, Hicke L, (2001) Distinct functional surface regions on ubiquitin. J Biol Chem 276: 30483-30489.
47. Lee S, Tsai YC, Mattera R, Smith WJ, Kostelansky MS, Weissman AM, Bonifacino JS, Hurley JH, (2006) Structural basis for ubiquitin recognition and autoubiquitination by Rabex-5. Nature Struct Mol Biol 13: 264-271.
48. van Wijk SJL, Timmers HTM, (2010) The family of ubiquitin-conjugating enzymes (E2s): deciding between life and death of proteins. FASEB J 24: 981-993.
49. Budhidarmo R, Nakatani Y, Day CL, (2012) RINGs hold the key to ubiquitin transfer. Trends Biochem Sci 37: 58-65.
50. Shin S, Case CL, Archer KA, Nogueira CV, Kobayashi KS, Flavell RA, Roy CR, Zamboni DS, (2008) Type IV secretion-dependent activation of host MAP kinases induces an increased proinflammatory cytokine response to Legionella pneumophila. PLoS Pathog 4: e1000220.
51. Ge J, Xu H, Li T, Zhou Y, Zhang Z, Li S, Liu L, Shao F, (2009) A Legionella type IV effector activates the NF-kappaB pathway by phosphorylating the IkappaB family of inhibitors. Proc Natl Acad Sci USA 106: 13725-13730.
52. Garcia-Vallve S, Guzman E, Montero MA, Romeu A, (2003) HGT-DB: a database of putative horizontally transferred genes in prokaryotic complete genomes. Nucleic Acids Res 31: 187-189.
53. Hanks SK, (2003) Genomic analysis of the eukaryotic protein kinase superfamily: a perspective. Genome Biol 4: 111.
54. Losick VP, Haenssler E, Moy MY, Isberg RR, (2010) LnaB: a Legionella pneumophila activator of NF-kappaB. Cell Microbiol 12: 1083-1097.
55. Meresse S, Unsworth KE, Habermann A, Griffiths G, Fang F, Martinez-Lorenzo MJ, Waterman SR, Gorvel JP, Holden DW, (2001) Remodelling of the actin cytoskeleton is essential for replication of intravacuolar Salmonella. Cell Microbiol 3: 567-577.
56. Unsworth KE, Way M, McNiven M, Machesky L, Holden DW, (2004) Analysis of the mechanisms of Salmonella-induced actin assembly during invasion of host cells and intracellular replication. Cell Microbiol 6: 1041-1055.
57. Wellbrock C, Karasarides M, Marais R, (2004) The RAF proteins take centre stage. Nat Rev Mol Cell Biol 5: 875-885.
58. Morgan E, Campbell JD, Rowe SC, Bispham J, Stevens MP, Bowen AJ, Barrow PA, Maskell DJ, Wallis TS, (2004) Identification of host-specific colonization factors of Salmonella enterica serovar Typhimurium. Mol Microbiol 54: 994-1010.
59. Odendall C, Rolhion N, Forster A, Poh J, Lamont DJ, Liu M, Freemont PS, Catling AD, Holden DW, (2012) The Salmonella kinase SteC targets the MAP kinase MEK to regulate the host actin cytoskeleton. Cell Host Microbe 12: 657-668.
60. Fernandez-Pinar P, Aleman A, Sondek J, Dohlman HG, Molina M, Martin H, (2012) The Salmonella Typhimurium effector SteC inhibits Cdc42-mediated signaling through binding to the exchange factor Cdc24 in Saccharomyces cerevisiae. Mol Biol Cell 23: 4430-4443.
61. Galyov EE, Hakansson S, Forsberg A, Wolf-Watz H, (1993) A secreted protein kinase of Yersinia pseudotuberculosis is an indispensable virulence determinant. Nature 361: 730-732.
62. Wiley DJ, Nordfeldth R, Rosenzweig J, DaFonseca CJ, Gustin R, Wolf-Watz H, Schesser K, (2006) The Ser/Thr kinase activity of the Yersinia protein kinase A (YpkA) is necessary for full virulence in the mouse, mollifying phagocytes, and disrupting the eukaryotic cytoskeleton. Microb Pathog 40: 234-243.
63. Hakansson S, Galyov EE, Rosqvist R, Wolf-Watz H, (1996) The Yersinia YpkA Ser/Thr kinase is translocated and subsequently targeted to the inner surface of the HeLa cell plasma membrane. Mol Microbiol 20: 593-603.
64. Letzelter M, Sorg I, Mota LJ, Meyer S, Stalder J, Feldman M, Kuhn M, Callebaut I, Cornelis GR, (2006) The discovery of SycO highlights a new function for type III secretion effector chaperones. EMBO J 25: 3223-3233.
65. Salomon D, Guo Y, Kinch LN, Grishin NV, Gardner KH, Orth K, (2013) Effectors of animal and plant pathogens use a common domain to bind host phosphoinositides. Nature Commun 4: 2973.
66. Juris SJ, Rudolph AE, Huddler D, Orth K, Dixon JE, (2000) A distinctive role for the Yersinia protein kinase: actin binding, kinase activation, and cytoskeleton disruption. Proc Natl Acad Sci USA 97: 9431-9436.
67. Trasak C, Zenner G, Vogel A, Yuksekdag G, Rost R, Haase I, Fischer M, Israel L, Imhof A, Linder S, Schleicher M, Aepfelbacher M, (2007) Yersinia protein kinase YopO is activated by a novel G-actin binding process. J Biol Chem 282: 2268-2277.
68. Pha K, Wright ME, Barr TM, Eigenheer RA, Navarro L, (2014) Regulation of Yersinia protein kinase A (YpkA) kinase activity by multisite autophosphorylation and identification of an N-terminal substrate-binding domain in YpkA. J Biol Chem 289: 26167-26177.
69. Navarro L, Koller A, Nordfelth R, Wolf-Watz H, Taylor S, Dixon JE, (2007) Identification of a molecular target for the Yersinia protein kinase A. Mol Cell 26: 465-477.
70. Ke Y, Tan Y, Wei N, Yang F, Yang H, Cao S, Wang X, Wang J, Han Y, Bi Y, Cui Y, Yan Y, Song Y, Yang X, Du Z, Yang R, (2014) Yersinia protein kinase A phosphorylates vasodilator-stimulated phosphoprotein to modify the host cytoskeleton. Cell Microbiol [VOL:PAGE #S].
71. Bliska JB, Guan KL, Dixon JE, Falkow S, (1991) Tyrosine phosphate hydrolysis of host proteins by an essential Yersinia virulence determinant. Proc Natl Acad Sci USA 88: 1187-1191.
72. Deleuil F, Mogemark L, Francis MS, Wolf-Watz H, Fallman M, (2003) Interaction between the Yersinia protein tyrosine phosphatase YopH and eukaryotic Cas/Fyb is an important virulence mechanism. Cell Microbiol 5: 53-64.
73. Andersson K, Carballeira N, Magnusson KE, Persson C, Stendahl O, Wolf-Watz H, Fallman M, (1996) YopH of Yersinia pseudotuberculosis interrupts early phosphotyrosine signalling associated with phagocytosis. Mol Microbiol 20: 1057-1069.
74. Black DS, Bliska JB, (1997) Identification of p130Cas as a substrate of Yersinia YopH (Yop51), a bacterial protein tyrosine phosphatase that translocates into mammalian cells and targets focal adhesions. EMBO J 16: 2730-2744.
75. Yao T, Mecsas J, Healy JI, Falkow S, Chien Y, (1999) Suppression of T and B lymphocyte activation by a Yersinia pseudotuberculosis virulence factor, yopH. J Exp Med 190: 1343-1350.
76. Rolan HG, Durand EA, Mecsas J, (2013) Identifying Yersinia YopH-targeted signal transduction pathways that impair neutrophil responses during in vivo murine infection. Cell Host Microbe 14: 306-317.
77. Persson C, Carballeira N, Wolf-Watz H, Fallman M, (1997) The PTPase YopH inhibits uptake of Yersinia, tyrosine phosphorylation of p130Cas and FAK, and the associated accumulation of these proteins in peripheral focal adhesions. EMBO J 16: 2307-2318.
78. Hamid N, Gustavsson A, Andersson K, McGee K, Persson C, Rudd CE, Fallman M, (1999) YopH dephosphorylates Cas and Fyn-binding protein in macrophages. Microb Pathog 27: 231-242.
79. Black DS, Marie-Cardine A, Schraven B, Bliska JB, (2000) The Yersinia tyrosine phosphatase YopH targets a novel adhesion-regulated signalling complex in macrophages. Cell Microbiol 2: 401-414.
80. Alonso A, Bottini N, Bruckner S, Rahmouni S, Williams S, Schoenberger SP, Mustelin T, (2004) Lck dephosphorylation at Tyr-394 and inhibition of T cell antigen receptor signaling by Yersinia phosphatase YopH. J Biol Chem 279: 4922-4928.
81. Gerke C, Falkow S, Chien YH, (2005) The adaptor molecules LAT and SLP-76 are specifically targeted by Yersinia to inhibit T cell activation. J Exp Med 201: 361-371.
82. de la Puerta ML, Trinidad AG, del Carmen Rodriguez M, Bogetz J, Sanchez Crespo M, Mustelin T, Alonso A, Bayon Y, (2009) Characterization of new substrates targeted by Yersinia tyrosine phosphatase YopH. PLoS One 4: e4431.
83. Barford D, Flint AJ, Tonks NK, (1994) Crystal structure of human protein tyrosine phosphatase 1B. Science 263: 1397-1404.
84. Hooft van Huijsduijnen R, (1998) Protein tyrosine phosphatases: counting the trees in the forest. Gene 225: 1-8.
85. Zhang ZY, Wang Y, Dixon JE, (1994) Dissecting the catalytic mechanism of protein-tyrosine phosphatases. Proc Natl Acad Sci USA 91: 1624-1627.
86. Stuckey JA, Schubert HL, Fauman EB, Zhang ZY, Dixon JE, Saper MA, (1994) Crystal structure of Yersinia protein tyrosine phosphatase at 2.5 A and the complex with tungstate. Nature 370: 571-575.
87. Zhang ZY, Dixon JE, (1993) Active site labeling of the Yersinia protein tyrosine phosphatase: the determination of the pKa of the active site cysteine and the function of the conserved histidine 402. Biochemistry 32: 9340-9345.
88. Sun JP, Wu L, Fedorov AA, Almo SC, Zhang ZY, (2003) Crystal structure of the Yersinia protein-tyrosine phosphatase YopH complexed with a specific small molecule inhibitor. J Biol Chem 278: 33392-33399.
89. Zhang ZY, (2001) Protein tyrosine phosphatases: prospects for therapeutics. Curr Opin Chem Biol 5: 416-423.
90. Zhang ZY, (2003) Chemical and mechanistic approaches to the study of protein tyrosine phosphatases. Acc Chem Res 36: 385-392.
91. Hengge AC, Sowa GA, Wu L, Zhang ZY, (1995) Nature of the transition state of the protein-tyrosine phosphatase-catalyzed reaction. Biochemistry 34: 13982-13987.
92. Wu L, Zhang ZY, (1996) Probing the function of Asp128 in the lower molecular weight protein-tyrosine phosphatase-catalyzed reaction. A pre-steady-state and steady-state kinetic investigation. Biochemistry 35: 5426-5434.
93. Zhang ZY, Palfey BA, Wu L, Zhao Y, (1995) Catalytic function of the conserved hydroxyl group in the protein tyrosine phosphatase signature motif. Biochemistry 34: 16389-16396.
94. Zhang ZY, Thieme-Sefler AM, Maclean D, McNamara DJ, Dobrusin EM, Sawyer TK, Dixon JE, (1993) Substrate specificity of the protein tyrosine phosphatases. Proc Natl Acad Sci USA 90: 4446-4450.
95. Whittier SK, Hengge AC, Loria JP, (2013) Conformational motions regulate phosphoryl transfer in related protein tyrosine phosphatases. Science 341: 899-903.
96. Phan J, Lee K, Cherry S, Tropea JE, Burke TR Jr, Waugh DS, (2003) High-resolution structure of the Yersinia pestis protein tyrosine phosphatase YopH in complex with a phosphotyrosyl mimetic-containing hexapeptide. Biochemistry 42: 13113-13121.
97. Ivanov MI, Stuckey JA, Schubert HL, Saper MA, Bliska JB, (2005) Two substrate-targeting sites in the Yersinia protein tyrosine phosphatase co-operate to promote bacterial virulence. Mol Microbiol 55: 1346-1356.
98. Woestyn S, Sory MP, Boland A, Lequenne O, Cornelis GR, (1996) The cytosolic SycE and SycH chaperones of Yersinia protect the region of YopE and YopH involved in translocation across eukaryotic cell membranes. Mol Microbiol 20: 1261-1271.
99. Vujanac M, Stebbins CE, (2013) Context-dependent protein folding of a virulence peptide in the bacterial and host environments: structure of an SycH-YopH chaperone-effector complex. Acta Cryst D 69: 546-554.
100. Evdokimov AG, Tropea JE, Routzahn KM, Copeland TD, Waugh DS, (2001) Structure of the N-terminal domain of Yersinia pestis YopH at 2.0 A resolution. Acta Cryst D 57: 793-799.
101. Montagna LG, Ivanov MI, Bliska JB, (2001) Identification of residues in the N-terminal domain of the Yersinia tyrosine phosphatase that are critical for substrate recognition. J Biol Chem 276: 5005-5011.
102. Khandelwal P, Keliikuli K, Smith CL, Saper MA, Zuiderweg ER, (2002) Solution structure and phosphopeptide binding to the N-terminal domain of Yersinia YopH: comparison with a crystal structure. Biochemistry 41: 11425-11437.
103. Sory MP, Boland A, Lambermont I, Cornelis GR, (1995) Identification of the YopE and YopH domains required for secretion and internalization into the cytosol of macrophages, using the cyaA gene fusion approach. Proc Natl Acad Sci USA 92: 11998-12002.
104. Kaniga K, Uralil J, Bliska JB, Galan JE, (1996) A secreted protein tyrosine phosphatase with modular effector domains in the bacterial pathogen Salmonella typhimurium. Mol Microbiol 21: 633-641.
105. Kulich SM, Yahr TL, Mende-Mueller LM, Barbieri JT, Frank DW, (1994) Cloning the structural gene for the 49-kDa form of exoenzyme S (exoS) from Pseudomonas aeruginosa strain 388. J Biol Chem 269: 10431-10437.
106. Forsberg A, Wolf-Watz H, (1990) Genetic analysis of the yopE region of Yersinia spp.: identification of a novel conserved locus, yerA, regulating yopE expression. J Bacteriol 172: 1547-1555.
107. Michiels T, Wattiau P, Brasseur R, Ruysschaert JM, Cornelis G, (1990) Secretion of Yop proteins by Yersiniae. Infect Immun 58: 2840-2849.
108. Stebbins CE, Galan JE, (2000) Modulation of host signaling by a bacterial mimic: structure of the Salmonella effector SptP bound to Rac1. Mol Cell 6: 1449-1460.
109. Stebbins CE, Galan JE, (2001) Maintenance of an unfolded polypeptide by a cognate chaperone in bacterial type III secretion. Nature 414: 77-81.
110. Fu Y, Galan JE, (1998) Identification of a specific chaperone for SptP, a substrate of the centisome 63 type III secretion system of Salmonella typhimurium. J Bacteriol 180: 3393-3399.
111. Fu Y, Galan JE, (1999) A salmonella protein antagonizes Rac-1 and Cdc42 to mediate host-cell recovery after bacterial invasion. Nature 401: 293-297.
112. Button JE, Galan JE, (2011) Regulation of chaperone/effector complex synthesis in a bacterial type III secretion system. Mol Microbiol 81: 1474-1483.
113. Murli S, Watson RO, Galan JE, (2001) Role of tyrosine kinases and the tyrosine phosphatase SptP in the interaction of Salmonella with host cells. Cell Microbiol 3: 795-810.
114. Lin SL, Le TX, Cowen DS, (2003) SptP, a Salmonella typhimurium type III-secreted protein, inhibits the mitogen-activated protein kinase pathway by inhibiting Raf activation. Cell Microbiol 5: 267-275.
115. Humphreys D, Hume PJ, Koronakis V, (2009) The Salmonella effector SptP dephosphorylates host AAA+ ATPase VCP to promote development of its intracellular replicative niche. Cell Host Microbe 5: 225-233.
116. Choi HW, Brooking-Dixon R, Neupane S, Lee CJ, Miao EA, Staats HF, Abraham SN, (2013) Salmonella typhimurium impedes innate immunity with a mast-cell-suppressing protein tyrosine phosphatase, SptP. Immunity 39: 1108-1120.
117. Li H, Xu H, Zhou Y, Zhang J, Long C, Li S, Chen S, Zhou JM, Shao F, (2007) The phosphothreonine lyase activity of a bacterial type III effector family. Science 315: 1000-1003.
118. Kim DW, Chu H, Joo DH, Jang MS, Choi JH, Park SM, Choi YJ, Han SH, Yun CH, (2008) OspF directly attenuates the activity of extracellular signal-regulated kinase during invasion by Shigella flexneri in human dendritic cells. Mol Immunol 45: 3295-3301.
119. Mazurkiewicz P, Thomas J, Thompson JA, Liu M, Arbibe L, Sansonetti P, Holden DW, (2008) SpvC is a Salmonella effector with phosphothreonine lyase activity on host mitogen-activated protein kinases. Mol Microbiol 67: 1371-1383.
120. Zhu Y, Li H, Long C, Hu L, Xu H, Liu L, Chen S, Wang DC, Shao F, (2007) Structural insights into the enzymatic mechanism of the pathogenic MAPK phosphothreonine lyase. Mol Cell 28: 899-913.
121. Chen L, Wang H, Zhang J, Gu L, Huang N, Zhou JM, Chai J, (2008) Structural basis for the catalytic mechanism of phosphothreonine lyase. Nature Struct Mol Biol 15: 101-102.
122. Zhang J, Shao F, Li Y, Cui H, Chen L, Li H, Zou Y, Long C, Lan L, Chai J, Chen S, Tang X, Zhou JM, (2007) A Pseudomonas syringae effector inactivates MAPKs to suppress PAMP-induced immunity in plants. Cell Host Microbe 1: 175-185.
123. Chang CI, Xu BE, Akella R, Cobb MH, Goldsmith EJ, (2002) Crystal structures of MAP kinase p38 complexed to the docking sites on its nuclear substrate MEF2A and activator MKK3b. Mol Cell 9: 1241-1249.
124. Bellon S, Fitzgibbon MJ, Fox T, Hsiao HM, Wilson KP, (1999) The structure of phosphorylated p38gamma is monomeric and reveals a conserved activation-loop conformation. Structure 7: 1057-1065.
125. Smith GK, Ke Z, Hengge AC, Xu D, Xie D, Guo H, (2009) Active-site dynamics of SpvC virulence factor from Salmonella typhimurium and density functional theory study of phosphothreonine lyase catalysis. J Phys Chem B 113: 15327-15333.
126. Ke Z, Smith GK, Zhang Y, Guo H, (2011) Molecular mechanism for eliminylation, a newly discovered post-translational modification. J Am Chem Soc 133: 11103-11105.
127. Pei Q, Christofferson A, Zhang H, Chai J, Huang N, (2011) Computational investigation of the enzymatic mechanisms of phosphothreonine lyase. Biophys Chem 157: 16-23.
128. Haneda T, Ishii Y, Shimizu H, Ohshima K, Iida N, Danbara H, Okada N, (2012) Salmonella type III effector SpvC, a phosphothreonine lyase, contributes to reduction in inflammatory response during intestinal phase of infection. Cell Microbiol 14: 485-499.
129. Harouz H, Rachez C, Meijer BM, Marteyn B, Donnadieu F, Cammas F, Muchardt C, Sansonetti P, Arbibe L, (2014) Shigella flexneri targets the HP1gamma subcode through the phosphothreonine lyase OspF. EMBO J 33: 2606-2622.
130. Zurawski DV, Mumy KL, Faherty CS, McCormick BA, Maurelli AT, (2009) Shigella flexneri type III secretion system effectors OspB and OspF target the nucleus to downregulate the host inflammatory response via interactions with retinoblastoma protein. Mol Microbiol 71: 350-368.
131. Reiterer V, Grossniklaus L, Tschon T, Kasper CA, Sorg I, Arrieumerlou C, (2011) Shigella flexneri type III secreted effector OspF reveals new crosstalks of proinflammatory signaling pathways during bacterial infection. Cell Signal 23: 1188-1196.
132. Ruckdeschel K, Machold J, Roggenkamp A, Schubert S, Pierre J, Zumbihl R, Liautard JP, Heesemann J, Rouot B, (1997) Yersinia enterocolitica promotes deactivation of macrophage mitogen-activated protein kinases extracellular signal-regulated kinase-1/2, p38, and c-Jun NH2-terminal kinase. Correlation with its inhibitory effect on tumor necrosis factor-alpha production. J Biol Chem 272: 15920-15927.
133. Palmer LE, Hobbie S, Galan JE, Bliska JB, (1998) YopJ of Yersinia pseudotuberculosis is required for the inhibition of macrophage TNF-alpha production and downregulation of the MAP kinases p38 and JNK. Mol Microbiol 27: 953-965.
134. Palmer LE, Pancetti AR, Greenberg S, Bliska JB, (1999) YopJ of Yersinia spp. is sufficient to cause downregulation of multiple mitogen-activated protein kinases in eukaryotic cells. Infect Immun 67: 708-716.
135. Schesser K, Spiik AK, Dukuzumuremyi JM, Neurath MF, Pettersson S, Wolf-Watz H, (1998) The yopJ locus is required for Yersinia-mediated inhibition of NF-kappaB activation and cytokine expression: YopJ contains a eukaryotic SH2-like domain that is essential for its repressive activity. Mol Microbiol 28: 1067-1079.
136. Orth K, Palmer LE, Bao ZQ, Stewart S, Rudolph AE, Bliska JB, Dixon JE, (1999) Inhibition of the mitogen-activated protein kinase kinase superfamily by a Yersinia effector. Science 285: 1920-1923.
137. Rawlings ND, Barrett AJ, Bateman A, (2012) MEROPS: the database of proteolytic enzymes, their substrates and inhibitors. Nucleic Acids Res 40: D343-350.
138. Mukherjee S, Keitany G, Li Y, Wang Y, Ball HL, Goldsmith EJ, Orth K, (2006) Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science 312: 1211-1214.
139. Paquette N, Conlon J, Sweet C, Rus F, Wilson L, Pereira A, Rosadini CV, Goutagny N, Weber AN, Lane WS, Shaffer SA, Maniatis S, Fitzgerald KA, Stuart L, Silverman N, (2012) Serine/threonine acetylation of TGFbeta-activated kinase (TAK1) by Yersinia pestis YopJ inhibits innate immune signaling. Proc Natl Acad Sci USA 109: 12710-12715.
140. Mittal R, Peak-Chew SY, McMahon HT, (2006) Acetylation of MEK2 and I kappa B kinase (IKK) activation loop residues by YopJ inhibits signaling. Proc Natl Acad Sci USA 103: 18574-18579.
141. Hao YH, Wang Y, Burdette D, Mukherjee S, Keitany G, Goldsmith E, Orth K, (2008) Structural requirements for Yersinia YopJ inhibition of MAP kinase pathways. PLoS One 3: e1375.
142. Mittal R, Peak-Chew SY, Sade RS, Vallis Y, McMahon HT, (2010) The acetyltransferase activity of the bacterial toxin YopJ of Yersinia is activated by eukaryotic host cell inositol hexakisphosphate. J Biol Chem 285: 19927-19934.
143. Collier-Hyams LS, Zeng H, Sun J, Tomlinson AD, Bao ZQ, Chen H, Madara JL, Orth K, Neish AS, (2002) Cutting edge: Salmonella AvrA effector inhibits the key proinflammatory, anti-apoptotic NF-kappa B pathway. J Immunol 169: 2846-2850.
144. Du F, Galan JE, (2009) Selective inhibition of type III secretion activated signaling by the Salmonella effector AvrA. PLoS Pathog 5: e1000595.
145. Jones RM, Wu H, Wentworth C, Luo L, Collier-Hyams L, Neish AS, (2008) Salmonella AvrA coordinates suppression of host immune and apoptotic defenses via JNK pathway blockade. Cell Host Microbe 3: 233-244.
146. Fehr D, Casanova C, Liverman A, Blazkova H, Orth K, Dobbelaere D, Frey J, Burr SE, (2006) AopP, a type III effector protein of Aeromonas salmonicida, inhibits the NF-kappaB signalling pathway. Microbiology 152: 2809-2818.
147. Trosky JE, Mukherjee S, Burdette DL, Roberts M, McCarter L, Siegel RM, Orth K, (2004) Inhibition of MAPK signaling pathways by VopA from Vibrio parahaemolyticus. J Biol Chem 279: 51953-51957.
148. Trosky JE, Li Y, Mukherjee S, Keitany G, Ball H, Orth K, (2007) VopA inhibits ATP binding by acetylating the catalytic loop of MAPK kinases. J Biol Chem 282: 34299-34305.
149. Tasset C, Bernoux M, Jauneau A, Pouzet C, Briere C, Kieffer-Jacquinod S, Rivas S, Marco Y, Deslandes L, (2010) Autoacetylation of the Ralstonia solanacearum effector PopP2 targets a lysine residue essential for RRS1-R-mediated immunity in Arabidopsis. PLoS Pathog 6: e1001202.
150. Kauppi AM, Nordfelth R, Uvell H, Wolf-Watz H, Elofsson M, (2003) Targeting bacterial virulence: inhibitors of type III secretion in Yersinia. Chem Biol 10: 241-249.
151. Marshall NC, Finlay BB, (2014) Targeting the type III secretion system to treat bacterial infections. Expert Opin Therap Targ 18: 137-152.
152. Koul A, Arnoult E, Lounis N, Guillemont J, Andries K, (2011) The challenge of new drug discovery for tuberculosis. Nature 469: 483-490.
153. Wei P, Wong WW, Park JS, Corcoran EE, Peisajovich SG, Onuffer JJ, Weiss A, Lim WA, (2012) Bacterial virulence proteins as tools to rewire kinase pathways in yeast and immune cells. Nature 488: 384-388.
154. Roberts E, Eargle J, Wright D, Luthey-Schulten Z, (2006) MultiSeq: unifying sequence and structure data for evolutionary analysis. BMC Bioinformatics 7: 382.